WALTHAM, Mass.--(BUSINESS WIRE)--PerkinElmer, Inc. (NYSE: PKI), a global technology leader in Health Sciences and Photonics, today announced a multi-year agreement with the King Faisal Specialist Hospital and Research Centre in Riyadh, Saudi Arabia, to support its expanded newborn screening program. Under the terms of the agreement, PerkinElmer will provide instrumentation, reagents, software and screening expertise that will help the King Faisal Hospital double its screening capacity by the end of 2008. The contract, to be executed through PerkinElmer’s regional distributor, HVD Vertriebs Gmbh, will also expand the hospital’s program from screening for one disorder to a total of four disorders.
